Qualissima: Clinical Trials

10 trials sponsored by Qualissima, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 2 unknown. 6 Not applicable, 2 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 2, Terminated 2, Unknown 2
Phase 12Completed 2
Phase 42Completed 1, Terminated 1

Follow Qualissima: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis
Photobiomodulation using CareMin650 at 6 Joules (curative intent), Photobiomodulation using CareMin650 at 3 Joules (prophylactic intent) - Oral Mucositis Due to Radiation, Radiation Dermatitis
Not applicableCompletedNeoMedLight722019-07-042021-04-30
A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088
IFB-088 (2.5-60.0mg) oral capsule, Placebo (2.5-60.mg) oral capsule, IFB-088 (15.0-50.0mg) oral capsule - Healthy Volunteers
Phase 1CompletedInFlectis BioScience722018-06-212022-01-26
Evaluation of Improved Preparation Time to a Coverage in Patients With Acute Wounds by Use of VistaCare® Versus Dressings
VistaCare®, Dressings - Leg Injury
Not applicableUnknownQualissima402016-11-012016-11-15
Virtual Reality and Concept of Control in the Treatment of Acrophobia
Exposure to anxiogenous environments, Imagery with functional MRI initial, Imagery with PET-scanner initial - Phobic Disorders
Not applicableUnknownQualissima602014-04-012015-10-30
Stability of rTMS on Cognition and Brain Networks on Healthy Subjects.
ineffective rTMS, active TBS, Sham TBS - Healthy
Not applicableTerminatedQualissima1582013-05-012016-04-19
Influence of Repetitive Transcranial Magnetic Stimulation (rTMS) Challenge on Cognitive and Functional Magnetic Resonance Imaging Markers in Healthy Subjects
rTMS/Active TBS, rTMS/Placebo TBS - Healthy
Not applicableTerminatedQualissima142011-12-012013-05-15
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
Lumbar puncture - MILD COGNITIVE IMPAIRMENT
Not applicableCompletedQualissima2292011-12-012015-11-02
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
Modafinil, Donepezil, Memantine - Healthy
Phase 1CompletedQualissima362011-11-012015-02-04
Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients
Imagery, pharmacogenetic sampling - Schizophrenia, Undifferentiated Type
Phase 4CompletedQualissima672010-12-012014-04-09
Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
Rasagiline, Pramipexole - Early-stage Parkinson's Disease
Phase 4TerminatedQualissima1122008-10-012012-05-28

Conditions studied

Acrophobia (1)  ·  Breast Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Head and Neck Neoplasms (1)  ·  Leg Injuries (1)  ·  Parkinson Disease (1)  ·  Phobic Disorders (1)  ·  Plaque, Amyloid (1)  ·  Radiodermatitis (1)  ·  Schizophrenia (1)  ·  Sleep Deprivation (1)  ·  Stomatitis (1)

Interventions

Bandages (1)  ·  Donepezil (1)  ·  Electroencephalography (1)  ·  Magnetic Resonance Imaging (1)  ·  Memantine (1)  ·  Modafinil (1)  ·  Pramipexole (1)  ·  Spinal Puncture (1)  ·  calcium D-pantothenate, L-cysteine drug combination (1)  ·  rasagiline (1)

Countries

France (8)  ·  Spain (3)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Christine Audebert (2)  ·  Andrea Soricelli, MD (1)  ·  Christine Audebert, MD (1)  ·  Dominique Casanova (1)  ·  Flavio Mariano Nobili, MD (1)  ·  Giovanni Frisoni, MD, MP (1)  ·  Jens Wiltfang, MD (1)  ·  Jose-Luis Molinuevo, PhD (1)  ·  Lucilla Parnetti, MD (1)  ·  Magda Tsolaki, MD (1)  ·  Mira Didic, MD (1)  ·  Olivier Blin, professor (1)

NIH funding

2009 (1), 2018 (1)